Chicago’s Rusty Perdew, a Partner in the Firm’s Class Actions Practice Group, shared his thoughts on the potential impact of the decision by the U.S. Supreme Court in Bristol-Myers Squibb v. Superior Court of California. Perdew noted: “Corporations facing a large volume of cases in venues chosen by plaintiffs will likely cite the Supreme Court to try to dismiss those claims.”
Read the full article here. This article also appeared in The New York Times, Business Insider and Fox Business, among others.
Sign up for our newsletter and get the latest to your inbox.